ADI-PEG20 Plus Low-Dose Cytarabine for the Treatment of Acute Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I Study of ADI-PEG20 Plus Low-Dose Cytarabine for the Treatment of Acute Myeloid Leukemia
Cancer Med 2021 Mar 30;[EPub Ahead of Print], HJ Tsai, HH Hsiao, YT Hsu, YC Liu, HW Kao, TC Liu, SF Cho, X Feng, A Johnston, JS Bomalaski, MC Kuo, TY ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.